Dana Flanders
Stock Analyst at Guggenheim
(n/a)
# 4,904
Out of 4,924 analysts
7
Total ratings
n/a
Success rate
-23.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dana Flanders
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VALN Valneva SE | Maintains: Buy | $17 → $15 | $7.82 | +91.82% | 1 | Mar 24, 2025 | |
| SCYX SCYNEXIS | Initiates: Buy | $25 | $0.71 | +3,426.09% | 1 | Jan 22, 2021 | |
| PCRX Pacira BioSciences | Initiates: Neutral | n/a | $22.54 | - | 1 | May 27, 2020 | |
| HRTX Heron Therapeutics | Initiates: Buy | $24 | $1.81 | +1,229.64% | 1 | May 27, 2020 | |
| COLL Collegium Pharmaceutical | Initiates: Neutral | n/a | $31.06 | - | 1 | May 27, 2020 | |
| EBS Emergent BioSolutions | Upgrades: Buy | $60 → $75 | $6.10 | +1,129.51% | 2 | Nov 2, 2018 |
Valneva SE
Mar 24, 2025
Maintains: Buy
Price Target: $17 → $15
Current: $7.82
Upside: +91.82%
SCYNEXIS
Jan 22, 2021
Initiates: Buy
Price Target: $25
Current: $0.71
Upside: +3,426.09%
Pacira BioSciences
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $22.54
Upside: -
Heron Therapeutics
May 27, 2020
Initiates: Buy
Price Target: $24
Current: $1.81
Upside: +1,229.64%
Collegium Pharmaceutical
May 27, 2020
Initiates: Neutral
Price Target: n/a
Current: $31.06
Upside: -
Emergent BioSolutions
Nov 2, 2018
Upgrades: Buy
Price Target: $60 → $75
Current: $6.10
Upside: +1,129.51%